Our mission is simple. We want people suffering from neurological disorders to walk, talk, see, hear, and feel again.
Our BCI Today
For some, BCI is a futuristic promise. For us, it is a device that works today. Our FDA-cleared configuration, the NeuroPort Array, is the gold standard of BCIs. It is a miniaturized, wired system with proven efficacy – more than 7 years chronically implanted in humans and nearly 10 years in non-human primates.
With more than a decade of hard work, fine-tuning and plenty of neural activity, our system draws on more data, published research, lab interaction and surgical experience than any other system in the world. Our technology doesn’t just restore function – it changes lives.
Our BCI Tomorrow
We are building the world’s leading technology platform for applications. Upcoming innovations include new surgical solutions, flexible materials, depth electrodes, additional channel count, and enhanced AI — and we just received a 2021 Breakthrough Designation from the FDA.
Follow our latest announcements here.
Our BCI Achievements
Our BCI Pioneers Can Move Again…
Aaron Ulland suffered a stroke paralyzing his left side. Blackrock’s BCI enabled him to move his arm again.
Dennis DeGrey sustained a spinal cord injury in 2007. Blackrock’s BCI allowed him to type text and email messages with just his thoughts.
Nathan Copeland sustained a spinal cord injury in 2004 and has been chronically implanted since November 2014. In a recent press conference, Nathan was able to feel Barack Obama’s hand.
Used by leading global research & clinical institutions.
Collaboration is our strength. With more than 500+ institutional partners around the world, our system has been used by the research community for more than a decade – a community dedicated to improving human lives.